|
2019
|
Invention
|
2 derivatives preparation. Provided is an improved process of vitamin K2 derivatives preparation,... |
|
2016
|
Invention
|
Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical co... |
|
2015
|
Invention
|
Process for manufacturing brinzolamide ophthalmic suspension and eye drops formulation. The inven... |
|
|
Invention
|
N-guanyl derivatives of 9-amino-5.1 1 -dimethyl-5h-indolo[2,3-b]quinoline having cytotoxic activi... |
|
2014
|
Invention
|
Process for the preparation of high purity amorphous pemetrexed disodium and crystalline forms of... |
|
2013
|
Invention
|
Process for preparation of bosentan monohydrate of pharmaceutical purity. A process for the prepa... |
|
|
Invention
|
Process for preparation of 3,24;16,22-di-o,o-isopropylideneprotoescigenin and crystalline forms t... |
|
|
Invention
|
Isoflavones for treating mucopolysaccharidoses.
A pharmaceutical composition including a pharmac... |
|
|
Invention
|
Process for preparation of prasugrel hydrochloride polymorphic form b of pharmaceutical purity. P... |
|
|
Invention
|
Process for preparation of high purity n- [2- (diethylamine) ethyl] - 5 - formyl - 2, 4 - dimethy... |
|
|
Invention
|
Process for preparation of prostaglandin f2 alpha analogues.
A convergent synthesis of the prost... |
|
|
Invention
|
Process for preparation of prostaglandin f2α analogues. A convergent synthesis of the prostagland... |
|
|
Invention
|
Process for the preparation of protoescigenin. Aesculus hippocastanum. The process includes the f... |
|
2012
|
Invention
|
The use of vitamin d analogues in combination with imatinib in therapy of non-small cell lung can... |
|
|
Invention
|
Preparation of protoescigenin from escin. The invention relates to the process for preparation of... |
|
|
Invention
|
Isoflavones for treating mucopolysaccharidoses. A method of treatment of mucopolysaccharidosis, t... |
|
|
Invention
|
Use of anastrozole and vitamin d analogue in the combined therapy of breast cancer. The invention... |
|
2010
|
Invention
|
New synthones for preparation of 19-nor vitamin d derivatives.
The present invention discloses t... |
|
|
Invention
|
New synthones for preparation of 19-nor vitamin d derivatives. The present invention discloses th... |
|
|
Invention
|
Combined therapy of colorectal carcinoma.
The invention relates to a combined therapy, wherein a... |
|
|
Invention
|
Combined therapy of colorectal carcinoma. The invention relates to a combined therapy, wherein ad... |
|
|
Invention
|
A method for amphiphilic drug loading in liposomes by ion gradient. An active loading of amphophi... |
|
|
Invention
|
Process for the preparation of calcipotriol. 1-6 alkyl or phenyl groups, in the presence of a str... |
|
2008
|
Invention
|
Process for the preparation of calcipotriol. Process comprising the step of reacting a C-22 pheny... |
|
|
Invention
|
Process for the preparation of pramipexole base and/or its salts.
The process for the preparatio... |
|
2007
|
Invention
|
Process for the preparation of docetaxel. The process for preparation of docetaxel consists in th... |
|
|
Invention
|
Process for preparation of 13,14-dihydro-pgf2 alpha derivatives. 2α, i.e., latanoprost. |
|
2006
|
Invention
|
Process for the preparation of pramipexole base and/or its salts. The process for the preparation... |
|
|
Invention
|
Isoflavones for treating mucopolysaccharidoses. The invention relates to the medical use of natur... |
|
|
Invention
|
Process for preparation of 13,14-dihydro-pgf2 alpha derivatives.
The invention relates to a proc... |
|
|
Invention
|
Process for preparation of 13,14-dihydro-pgf2&agr; derivatives. Invention relates to the process ... |
|
2005
|
Invention
|
Process for preparation of imatinib base. An improved process for the preparation of imatinib bas... |
|
|
Invention
|
A process for preparation of imatinib base. The invention provides an improved process for prepar... |
|
|
Invention
|
Process for preparation of pharmaceutically pure anhydrous calcipotriol. A process for the prepar... |
|
|
Invention
|
Process for preparation of a pharmaceutical grade calcipotriol anhydrous. A process for the prepa... |
|
|
Invention
|
Novel salt of montelukast.
The invention relates to a novel salt of montelukast with tert-butyla... |
|
|
Invention
|
Salt of montelukast with tert.-butylamine. The invention relates to a novel salt of montelukast w... |
|
|
Invention
|
Controlled-release formulation comprising tamsulosin hydrochloride.
Taught herein is a solid, or... |
|
|
Invention
|
Controlled-release formulation comprising tamsulosin hydrochloride. A solid oral controlled-relea... |
|
|
Invention
|
Process and intermediates for the preparation of sulfonyl derivatives of cholecalciferol.
Prepar... |
|
|
Invention
|
Process and intermediates to prepare the sulphonyl derivatives of cholecalciferol. Preparation of... |
|
|
Invention
|
Process for the preparation of 2-[n-[{s)-1-ethoxycarbonyl-3-phenylpropyl]-(s)-alanyl]-(1s,3s,5s)-... |
|
|
Invention
|
A process for the preparation of 2-⏧n- ⏧(s)-1-ethoxycarbonyl-3-phenylpropyl]-(s)-alanyl... |
|
|
Invention
|
Crystalline polymorphs of methanesulfonic acid addition salts of imatinib. This invention relates... |
|
|
Invention
|
Crystalline methanesulfonic acid addition salts of imatinib. The invention relates to the methane... |
|
|
Invention
|
Liposomal formulations of the antineoplastic agents. The invention relates to the liposomal formu... |
|
2003
|
Invention
|
Process and intermediates to prepare17beta-hydroxy-7alpha-methyl-19-nor-17alpha-pregn -5(10)-en-2... |
|
|
Invention
|
Methods for preparation of olanzapine polymorphic form i. The invention relates to the methods fo... |
|
2002
|
Invention
|
Analogs of human growth hormone-releasing hormone, their preparation and use. 29 is D-Arg, hArg, ... |
